Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis
Background Despite the high burden of atrial fibrillation in cardiac amyloidosis (CA), the safety of catheter ablation therapy in CA is not well established. We sought to examine short‐term safety outcomes following atrial fibrillation ablation in patients with CA compared with matched patients with...
Main Authors: | Hassan A. Alhassan, Aleesha Kainat, Joseph Donohue, Scott J. Baumgartner, Harriet Akunor, Samir Saba, Sandeep Jain, Prem Soman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-07-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.122.029339 |
Similar Items
-
Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy
by: Yoon-Kee Siow, et al.
Published: (2024-01-01) -
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication
by: Raffaella Mistrulli, et al.
Published: (2024-01-01) -
Electrophysiologic characteristics and catheter ablation results of tachycardia-induced cardiomyopathy in children with structurally normal heart
by: Hasan Candaş Kafalı, et al.
Published: (2020-11-01) -
Double Gain: The Radio Frequency Catheter Ablation of Ventricular Aneurysm Related Recurrent Ventricular Tachycardia on a Tremendous Cardiac Outpouching
by: Kexin Li, et al.
Published: (2022-08-01) -
The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation
by: José Nicolás López-Canoa, et al.
Published: (2022-09-01)